Total planned funding: $1,105,113,706
Clear active filters
HTXD: Treatment: ARV Drugs
Private Contractor
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $226,501,371 |
Zambia | $148,490,739 |
Tanzania | $137,427,637 |
Mozambique | $101,899,309 |
Côte d'Ivoire | $89,231,308 |
Kenya | $70,955,240 |
Uganda | $65,900,933 |
Zimbabwe | $58,756,260 |
Rwanda | $51,918,516 |
Ethiopia | $43,459,017 |
Vietnam | $34,633,895 |
Haiti | $23,464,103 |
South Africa | $13,080,710 |
Democratic Republic of the Congo | $12,035,809 |
Ukraine | $8,800,000 |
Eswatini | $6,071,426 |
Guyana | $4,831,447 |
Namibia | $2,777,688 |
South Sudan | $1,747,184 |
Botswana | $1,705,000 |
Burundi | $1,242,114 |
Malawi | $150,000 |
Angola | $34,000 |
Organizational Types
Private Contractor | $1,105,113,706 |
Program Areas
Treatment | $1,105,113,706 |
Budget Codes
HTXD: Treatment: ARV Drugs | $1,105,113,706 |
Top Partner Programs
Chemonics International:
$429,043,235
View countries